News | November 18, 2014

Mevion and Philips Collaborate to Offer Treatment Planning Solutions for Proton Pencil Beam Scanning

Companies to develop Pinnacle³ proton planning for the Mevion S250 proton therapy system featuring Hyperscan

Mevion Medical Systems, Inc. and Philips Radiation Oncology Systems are collaborating to combine the treatment planning capability of Philips’ Pinnacle³ radiation therapy planning system with the Mevion S250 solution with Hyperscan, Mevion’s new pencil beam scanning technology that is capable of scanning a tumor in seconds.

Pinnacle³ currently supports the Mevion S250, the world’s smallest proton therapy platform. The new collaboration will focus on enabling the Pinnacle³ system to also support Hyperscan.

Hyperscan is an advanced form of pencil-beam scanning and is only available on the Mevion S250. Since Pinnacle³ is already being used by certain Mevion S250 users, it’s only fitting that we work together to develop planning for Hyperscan,” said Joe Jachinowski, the president and chief executive officer of Mevion Medical Systems.

“We’re really pleased to be collaborating with Mevion as it introduces Hyperscan,” said Sue Wallace, PhD, general manager of Philips Radiation Oncology Systems. “At Philips, treatment planning is a critical element of informed therapy guidance, and the integration of Philips imaging and planning with therapy delivery systems is essential.”

The first site to use Pinnacle³ with the Mevion S250 is the UF Health Cancer Center at Orlando Health. Omar Zeidan, Ph.D., the center’s chief of proton therapy physics, noted, “The collaboration between Philips and Mevion will give world-class cancer centers like ours the ability to offer patients all the benefits of HYPERSCAN combined with the accuracy and reliability of Pinnacle³.”  Zeidan added, “This will help lead to well-planned and well-executed proton therapy sessions that accurately target tumors.”

Hyperscan’s patented technology, paired with the direct and efficient proton beam generation of the Mevion S250 platform, allows tumor volumes to be quickly scanned in a matter of seconds. This speed makes Hyperscan’s treatment delivery much less sensitive to patient and tumor motion. 

The Mevion S250’s revolutionary compact design removes the obstacles of size, complexity and cost that exist with conventional proton therapy systems without compromising beam quality or patient care. It was first installed at Barnes Jewish Hospital in St. Louis. Five other Mevion S250 installations are currently in process.

HYPERSCAN has not been cleared by the USFDA for clinical use.

For more information: www.mevion.com

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
Catharina Hospital

Catharina Hospital

Sponsored Content | Case Study | Treatment Planning | July 05, 2017
Recently, the oncology department needed to update its radiation therapy treatment planning system. The department...

Photo courtesy of RaySearch

Feature | Treatment Planning | July 05, 2017 | By Jeff Zagoudis
While radiation oncologists have a number of proven techniques at their disposal for treating patients, the reality is...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
Overlay Init